Overview
Discounted cash flow
Income / accounting-based
Multiples & assets
Scenario
Toolbox
Weighted blend
$162.13
+31.49% vs spot
Strong Buy
Spot price
$123.30
Mkt cap $23.92B
subtle cardAnalyst PT consensus
$133.67
+8.41% vs spot
subtle cardMethods covered
16 / 16
13 in blend
subtle cardFootball field
BG · fair-value range by method
Method comparison
BG · fair value by valuation framework
| Method | Category | Fair value | Range | vs spot | Weight | Driver | Conf. |
|---|---|---|---|---|---|---|---|
| DDM · Gordon | ddm | $67.45 | $52.78 – $93.42 | -45.30% | — | D₁ 2.34, kₑ 7.3%, gₗ 3.7% | med |
| DDM · H-model | ddm | $136.88 | $99.47 – $203.09 | +11.01% | — | D₀ 2.34, g₀=25.0%, gₗ=3.7%, H 5y | med |
| DDM · multi-stage | ddm | $107.31 | $91.22 – $123.41 | -12.97% | 9.2% | 5y schedule 25.0% → 3.7%, kₑ 7.3% | high |
| Residual income | income | $83.80 | $73.75 – $93.86 | -32.03% | 18.3% | BV 88.85, ROE 4.7% → kₑ | high |
| EVA / MVA | income | $383.82 | $337.76 – $429.88 | +211.29% | 12.8% | IC 33.2B, WACC 4.9% | high |
| P/E · sector | multiple | $108.24 | $95.25 – $121.23 | -12.21% | 22.0% | EPS 4.92 × peer P/E 22.0 | med |
| P/S · sector | multiple | $573.85 | $487.77 – $659.93 | +365.41% | 5.5% | Rev/sh 358.66 × peer P/S 1.60 | med |
| EV / EBITDA | multiple | $45.21 | $39.79 – $50.64 | -63.33% | 18.3% | EBITDA × peer 14.0× − ND 15.8B | high |
| EV / EBIT | multiple | $10.15 | $8.63 – $11.68 | -91.76% | 3.7% | EBIT × peer 16.8× − ND | med |
| EV / Sales | multiple | $407.11 | $346.04 – $468.17 | +230.17% | 3.7% | Sales × peer 1.36× − ND | med |
| PEG-anchored | multiple | $196.80 | $167.28 – $226.32 | +59.61% | 1.8% | PEG=1, fwd EPS g 86.0% | med |
| Earnings power | intrinsic | $5.83 | $5.13 – $6.53 | -95.27% | 0.9% | NOPAT / WACC, no growth | med |
| Graham revised | intrinsic | $235.41 | $200.10 – $270.72 | +90.92% | 0.9% | EPS×(8.5+2g)·4.4/Y | low |
| Lynch P/E=g | intrinsic | $123.00 | $104.55 – $141.45 | -0.24% | 0.9% | PE = g (25.0) | low |
| Book NAV | asset | $88.85 | $84.41 – $93.29 | -27.94% | 1.8% | (Assets − Liabilities) / Shares | high |
| Liquidation | asset | $22.46 | $19.09 – $25.83 | -81.78% | — | Cash 100% + non-cash 70% − Liab. | low |
Cost-of-capital build-up
CAPM cost of equity, after-tax cost of debt, WACC. Risk-free as of 2026-05-12.
| Risk-free rate (US 10y Treasury)rf | 4.46% |
| Equity beta (0.63)β | × 0.63 |
| Equity risk premiumERP | 4.46% |
| Cost of equity (CAPM)kₑ | 7.26% |
| Pre-tax cost of debtkd | 3.20% |
| Effective tax ratet | 21.3% |
| After-tax cost of debt | 2.52% |
| Equity weight$17.4B | 50.7% |
| Debt weight$17.0B | 49.3% |
| WACC | 4.92% |
Growth assumptions
Blended forward growth used as DCF default; terminal pegged to long-run nominal GDP.
| Analyst forward revenue growthFMP | 30.90% |
| Analyst forward EPS growthFMP | 85.95% |
| Historical 5y revenue CAGRFY | 4.42% |
| Historical 5y EPS CAGRFY | -22.50% |
| Sustainable g (ROE × retention)Δ | 2.07% |
| Blended near-term growth (g₀) | 25.00% |
| Terminal growth (gₗ) | 3.66% |
Sources
- FMP /analyst-estimates— 8 rows(as of 2021-12-30)
- Treasury rates · 10y— 4.46% rf(as of 2026-05-12)
- market_risk_premium · DB— 4.46% ERP(as of 2026-05-13)
- Sector multiple defaults— Consumer Defensive (live sector PE unavailable)
- FMP /price-target-consensus— mean $133.67
This page is generated by a quantitative valuation engine for research purposes only and does not constitute investment advice. Methodology follows standard CFA / Damodaran frameworks; assumptions are driven by analyst consensus from Financial Modeling Prep and reported financial statements.